XTLB
XTL Biopharmaceuticals
XTLB
XTLB
3 hedge funds and large institutions have $155K invested in XTL Biopharmaceuticals in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$52K |
| 2 |
2
Morgan Stanley
New York
|
$21K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $82K | 25,961 | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $52K | 16,309 | +10,989 | +207% |
|
|
3
Morgan Stanley
New York
| $21K | 6,660 | +1,100 | +20% |
|